Difference between revisions of "Team:Dalhousie/Parts"

Latest revision as of 00:27, 2 November 2017

Parts

Protocol	Page
Alpha-L-Arabinofuranosidase	BBa_K2331000
Endoxylanase	BBa_K2331001
Beta-Xylanase	BBa_K2331002
Beta-glucosidase	BBa_K2331003
Periplasmic-Localizing Endoglucanase	BBa_K2331004

@@ Line 57: / Line 57: @@
      <ul class="nav navbar-nav navbar-center">
-       <li class="active" ><a href="https://2017.igem.org/Team:Dalhousie/test3" style=" color: white;">Home</a></li>
+       <li class="active" ><a href="https://2017.igem.org/Team:Dalhousie" style=" color: white;">Home</a></li>
 <li class="dropdown" >
@@ Line 90: / Line 90: @@
          </ul>
   </li>
 <li class="dropdown">
@@ Line 96: / Line 97: @@
          <ul class="dropdown-menu" style=" background-color: rgba(193,211,93,0.8);">
          <li><a href="https://2017.igem.org/Team:Dalhousie/Human_Practices">Summary</a></li>
-           <li><a href="https://2017.igem.org/Team:Dalhousie/HP/Silver">Silver HP</a></li>
+           <li><a href="https://2017.igem.org/Team:Dalhousie/HP/Silver">Science Communication</a></li>
            <li><a href="https://2017.igem.org/Team:Dalhousie/HP/Gold_Integrated">Integrated and Gold</a></li>
            <li><a href="https://2017.igem.org/Team:Dalhousie/Engagement">Public Engagement</a></li>
-        <li><a href="https://2017.igem.org/Team:Dalhousie/HP/Ethics">Ethics</a></li>
+<li><a href="https://2017.igem.org/Team:Dalhousie/SocialMedia">Social Media</a></li>
          </ul>
        </li>
@@ Line 153: / Line 154: @@
-<img src= "https://static.igem.org/mediawiki/2017/5/53/Dalparts.jpg" style="top:0px; left:0px; padding-bottom:0px; position:fixed; width:100%; height: 100%; z-index:-100; " align="center" height="70%" width="70%">
+<img src= "https://static.igem.org/mediawiki/2017/3/39/Dallalala.jpg" style="top:0px; left:0px; padding-bottom:0px; position:fixed; width:100%; height: 100%; z-index:-100; " align="center" height="70%" width="70%">
@@ Line 198: / Line 199: @@
-        <div class="panel" id="panel2">
+ <div class="panel" id="panel2">
              <div class="inner">
 <center>
@@ Line 207: / Line 208: @@
    </tr>
    <tr>
-     <td>CMC</td>
+     <td>Alpha-L-Arabinofuranosidase</td>
-     <td><a href="https://static.igem.org/mediawiki/2017/1/1f/Dal_CMCprotocol.pdf" style="color: #C1D35D">click here</a></td></td>
+     <td><a href="http://parts.igem.org/Part:BBa_K2331000" style="color: #C1D35D" target="_blank">BBa_K2331000</a></td>
    </tr>
    <tr>
-     <td>Attributions</td>
+     <td>Endoxylanase</td>
-    <td><a href="https://2017.igem.org/Team:Dalhousie/Attributions" style="color: #C1D35D">click here</a></td>
+   <td><a href="http://parts.igem.org/Part:BBa_K2331001" style="color: #C1D35D" target="_blank">BBa_K2331001</a></td>
-     <td>&#10004;</td>
+  </tr>
+<tr>
+     <td>Beta-Xylanase</td>
+  <td><a href="http://parts.igem.org/Part:BBa_K2331002" style="color: #C1D35D" target="_blank">BBa_K2331002</a></td>
    </tr>
    <tr>
-     <td>Interlab</td>
+     <td>Beta-glucosidase</td>
-    <td><a href="https://2017.igem.org/Team:Dalhousie/InterLab" style="color:  #C1D35D">click here</a></td>
+  <td><a href="http://parts.igem.org/Part:BBa_K2331003" style="color: #C1D35D" target="_blank">BBa_K2331003</a></td>
-     <td>&#10004;</td>
+  </tr>
+<tr>
+     <td>Periplasmic-Localizing Endoglucanase</td>
+  <td><a href="http://parts.igem.org/Part:BBa_K2331004" style="color: #C1D35D" target="_blank">BBa_K2331004</a></td>
    </tr>
 </table></center>
-</br>parts</br>
-Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <groupparts> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.
-Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</br>
-Note that parts must be documented on the Registry. This page serves to showcase the parts you have made. Future teams and other users and are much more likely to find parts by looking in the Registry than by looking at your team wiki.</br>
-The information needed to initially create a part on the Registry is:
-Part Name,
-Part type,
-Creator,
-Sequence,
-Short Description (60 characters on what the DNA does),
-Long Description (Longer description of what the DNA does),
-Design considerations,
-We encourage you to put up much more information as you gather it over the summer. If you have images, plots, characterization data and other information, please also put it up on the part page.
              </div>
@@ Line 249: / Line 240: @@
          <div class="panel panel-red" id="panel3">
              <div class="inner">
-       <p style="text-align:center; color:white; font-size: 30px; margin-top:100px;">
+      <p style="text-align: center; ">
-Learn more... hopefully have links to next pages here</p>
+<a href="http://www.plosibilities.wordpress.com"><img src="https://static.igem.org/mediawiki/2017/archive/8/8c/20171031235427%21Dalscreen.png" height="20%" width="20%" ></a>
+<img src="https://static.igem.org/mediawiki/parts/d/d7/Porcupinelogo2017.png" height="20%" width="20%" >
+<img src="https://static.igem.org/mediawiki/2017/e/ef/Whitetigerlogo.png" height="20%" width="20%" >
+</p>
              </div>
@@ Line 340: / Line 334: @@
 #panel2{
 width:100%;
-height: 700px;
+height: 100%;
 margin-bottom:0px;
-background: black;
+background: rgba(35,47,19,0.3);
 text-align:center;
@@ Line 348: / Line 342: @@
 #panel3{
 width:100%;
-height: 200px;
+height: 100%;
 margin-bottom:-100px;
 background: rgba(35,47,19,0.9);